Anticoagulant does not reduce rate of ischemic events among certain patients undergoing PCI
Sunday, September 1, 2013 - 20:30
in Health & Medicine
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes undergoing a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a new study.